nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—SLC6A4—Alzheimer's disease	0.284	0.587	CbGaD
Dexmethylphenidate—CYP2D6—Alzheimer's disease	0.2	0.413	CbGaD
Dexmethylphenidate—CYP2D6—Rivastigmine—Alzheimer's disease	0.102	0.432	CbGbCtD
Dexmethylphenidate—CYP2D6—Donepezil—Alzheimer's disease	0.0817	0.345	CbGbCtD
Dexmethylphenidate—CYP2D6—Galantamine—Alzheimer's disease	0.0526	0.223	CbGbCtD
Dexmethylphenidate—SLC6A2—locus ceruleus—Alzheimer's disease	0.00987	0.298	CbGeAlD
Dexmethylphenidate—SLC6A3—telencephalic ventricle—Alzheimer's disease	0.0058	0.175	CbGeAlD
Dexmethylphenidate—SLC6A3—Alpha-synuclein signaling—KLK6—Alzheimer's disease	0.0018	0.0611	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—forebrain—Alzheimer's disease	0.00151	0.0458	CbGeAlD
Dexmethylphenidate—SLC6A3—telencephalon—Alzheimer's disease	0.00139	0.0421	CbGeAlD
Dexmethylphenidate—SLC6A4—forebrain—Alzheimer's disease	0.00139	0.042	CbGeAlD
Dexmethylphenidate—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—Alzheimer's disease	0.0013	0.0441	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—telencephalon—Alzheimer's disease	0.00128	0.0386	CbGeAlD
Dexmethylphenidate—SLC6A2—forebrain—Alzheimer's disease	0.00122	0.0369	CbGeAlD
Dexmethylphenidate—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—Alzheimer's disease	0.00113	0.0384	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—telencephalon—Alzheimer's disease	0.00112	0.034	CbGeAlD
Dexmethylphenidate—SLC6A4—Synaptic Vesicle Pathway—SYP—Alzheimer's disease	0.00102	0.0347	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Synaptic Vesicle Pathway—SLC18A3—Alzheimer's disease	0.000833	0.0283	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—nervous system—Alzheimer's disease	0.000822	0.0249	CbGeAlD
Dexmethylphenidate—SLC6A3—central nervous system—Alzheimer's disease	0.000792	0.0239	CbGeAlD
Dexmethylphenidate—SLC6A3—cerebellum—Alzheimer's disease	0.000774	0.0234	CbGeAlD
Dexmethylphenidate—SLC6A4—nervous system—Alzheimer's disease	0.000753	0.0228	CbGeAlD
Dexmethylphenidate—SLC6A4—Monoamine Transport—PVRL2—Alzheimer's disease	0.000751	0.0255	CbGpPWpGaD
Dexmethylphenidate—Cyclopentolate—BCHE—Alzheimer's disease	0.000749	0.351	CrCbGaD
Dexmethylphenidate—SLC6A4—central nervous system—Alzheimer's disease	0.000725	0.0219	CbGeAlD
Dexmethylphenidate—SLC6A3—Alpha-synuclein signaling—SNCA—Alzheimer's disease	0.000703	0.0239	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—forebrain—Alzheimer's disease	0.000669	0.0202	CbGeAlD
Dexmethylphenidate—SLC6A3—Parkinsons Disease Pathway—LRRK2—Alzheimer's disease	0.000666	0.0226	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—nervous system—Alzheimer's disease	0.000663	0.0201	CbGeAlD
Dexmethylphenidate—SLC6A2—Monoamine Transport—PVRL2—Alzheimer's disease	0.000645	0.0219	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—central nervous system—Alzheimer's disease	0.000639	0.0193	CbGeAlD
Dexmethylphenidate—Methylphenidate—SLC6A4—Alzheimer's disease	0.000633	0.296	CrCbGaD
Dexmethylphenidate—SLC6A3—brain—Alzheimer's disease	0.000628	0.019	CbGeAlD
Dexmethylphenidate—CYP2D6—telencephalon—Alzheimer's disease	0.000615	0.0186	CbGeAlD
Dexmethylphenidate—SLC6A3—Parkinsons Disease Pathway—SNCA—Alzheimer's disease	0.000597	0.0203	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—brain—Alzheimer's disease	0.000576	0.0174	CbGeAlD
Dexmethylphenidate—SLC6A3—Monoamine Transport—PVRL2—Alzheimer's disease	0.000572	0.0194	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Monoamine Transport—ACHE—Alzheimer's disease	0.000562	0.0191	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Alpha-synuclein signaling—MAOB—Alzheimer's disease	0.000543	0.0184	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—brain—Alzheimer's disease	0.000507	0.0153	CbGeAlD
Dexmethylphenidate—SLC6A2—Monoamine Transport—ACHE—Alzheimer's disease	0.000483	0.0164	CbGpPWpGaD
Dexmethylphenidate—Methylphenidate—CYP2D6—Alzheimer's disease	0.000445	0.208	CrCbGaD
Dexmethylphenidate—SLC6A2—Monoamine Transport—SLC6A4—Alzheimer's disease	0.000444	0.0151	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Serotonin Transporter Activity—IL1B—Alzheimer's disease	0.000441	0.015	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A6—Alzheimer's disease	0.000429	0.0146	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Monoamine Transport—ACHE—Alzheimer's disease	0.000428	0.0145	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Alpha-synuclein signaling—PTK2B—Alzheimer's disease	0.000404	0.0137	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Monoamine Transport—SLC6A4—Alzheimer's disease	0.000393	0.0134	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—MAP2—Alzheimer's disease	0.000387	0.0131	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A6—Alzheimer's disease	0.00038	0.0129	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—nervous system—Alzheimer's disease	0.000363	0.011	CbGeAlD
Dexmethylphenidate—CYP2D6—central nervous system—Alzheimer's disease	0.00035	0.0106	CbGeAlD
Dexmethylphenidate—CYP2D6—cerebellum—Alzheimer's disease	0.000342	0.0103	CbGeAlD
Dexmethylphenidate—Ipratropium bromide—CYP2D6—Alzheimer's disease	0.000308	0.144	CrCbGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.000282	0.00959	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	0.000281	0.00954	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—brain—Alzheimer's disease	0.000278	0.00839	CbGeAlD
Dexmethylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000251	0.00854	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	0.000249	0.00845	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000248	0.00843	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.00024	0.00815	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.00024	0.00815	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000233	0.0079	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Alzheimer's disease	0.000229	0.00777	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—ACHE—Alzheimer's disease	0.000217	0.00737	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.000213	0.00723	CbGpPWpGaD
Dexmethylphenidate—Bradycardia—Rivastigmine—Alzheimer's disease	0.000207	0.000961	CcSEcCtD
Dexmethylphenidate—Hallucination—Memantine—Alzheimer's disease	0.000206	0.00096	CcSEcCtD
Dexmethylphenidate—Shock—Galantamine—Alzheimer's disease	0.000206	0.000959	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Memantine—Alzheimer's disease	0.000206	0.000958	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Galantamine—Alzheimer's disease	0.000205	0.000955	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000205	0.000954	CcSEcCtD
Dexmethylphenidate—Chills—Donepezil—Alzheimer's disease	0.000205	0.000954	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Memantine—Alzheimer's disease	0.000205	0.000953	CcSEcCtD
Dexmethylphenidate—Tachycardia—Galantamine—Alzheimer's disease	0.000205	0.000951	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Donepezil—Alzheimer's disease	0.000204	0.000949	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000204	0.00693	CbGpPWpGaD
Dexmethylphenidate—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000204	0.000949	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Memantine—Alzheimer's disease	0.000204	0.000948	CcSEcCtD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000204	0.00692	CbGpPWpGaD
Dexmethylphenidate—Rhinitis—Rivastigmine—Alzheimer's disease	0.000204	0.000946	CcSEcCtD
Dexmethylphenidate—Skin disorder—Galantamine—Alzheimer's disease	0.000204	0.000946	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Memantine—Alzheimer's disease	0.000203	0.000946	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000203	0.000944	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Alzheimer's disease	0.000203	0.00688	CbGpPWpGaD
Dexmethylphenidate—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000203	0.000942	CcSEcCtD
Dexmethylphenidate—Hallucination—Rivastigmine—Alzheimer's disease	0.000202	0.000939	CcSEcCtD
Dexmethylphenidate—Alopecia—Donepezil—Alzheimer's disease	0.000202	0.000939	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000202	0.000937	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000201	0.000932	CcSEcCtD
Dexmethylphenidate—Mental disorder—Donepezil—Alzheimer's disease	0.0002	0.000931	CcSEcCtD
Dexmethylphenidate—Visual impairment—Memantine—Alzheimer's disease	0.0002	0.00093	CcSEcCtD
Dexmethylphenidate—Anorexia—Galantamine—Alzheimer's disease	0.0002	0.000929	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.0002	0.000928	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000199	0.000925	CcSEcCtD
Dexmethylphenidate—Malnutrition—Donepezil—Alzheimer's disease	0.000199	0.000925	CcSEcCtD
Dexmethylphenidate—Erythema—Donepezil—Alzheimer's disease	0.000199	0.000925	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Memantine—Alzheimer's disease	0.000196	0.000912	CcSEcCtD
Dexmethylphenidate—Visual impairment—Rivastigmine—Alzheimer's disease	0.000196	0.00091	CcSEcCtD
Dexmethylphenidate—Tension—Donepezil—Alzheimer's disease	0.000195	0.000908	CcSEcCtD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	0.000195	0.00661	CbGpPWpGaD
Dexmethylphenidate—Eye disorder—Memantine—Alzheimer's disease	0.000194	0.000902	CcSEcCtD
Dexmethylphenidate—Nervousness—Donepezil—Alzheimer's disease	0.000193	0.000899	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Memantine—Alzheimer's disease	0.000193	0.000896	CcSEcCtD
Dexmethylphenidate—Flushing—Memantine—Alzheimer's disease	0.000193	0.000896	CcSEcCtD
Dexmethylphenidate—Back pain—Donepezil—Alzheimer's disease	0.000192	0.000895	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000192	0.000893	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000192	0.00652	CbGpPWpGaD
Dexmethylphenidate—Muscle spasms—Donepezil—Alzheimer's disease	0.000191	0.000889	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000191	0.000888	CcSEcCtD
Dexmethylphenidate—Eye disorder—Rivastigmine—Alzheimer's disease	0.00019	0.000882	CcSEcCtD
Dexmethylphenidate—Insomnia—Galantamine—Alzheimer's disease	0.00019	0.000881	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000188	0.000876	CcSEcCtD
Dexmethylphenidate—Flushing—Rivastigmine—Alzheimer's disease	0.000188	0.000876	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000188	0.0064	CbGpPWpGaD
Dexmethylphenidate—Angiopathy—Memantine—Alzheimer's disease	0.000188	0.000875	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Galantamine—Alzheimer's disease	0.000188	0.000875	CcSEcCtD
Dexmethylphenidate—SLC6A4—Monoamine Transport—IL1B—Alzheimer's disease	0.000188	0.00638	CbGpPWpGaD
Dexmethylphenidate—Vision blurred—Donepezil—Alzheimer's disease	0.000188	0.000872	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Memantine—Alzheimer's disease	0.000187	0.000872	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Memantine—Alzheimer's disease	0.000187	0.00087	CcSEcCtD
Dexmethylphenidate—Tremor—Donepezil—Alzheimer's disease	0.000186	0.000867	CcSEcCtD
Dexmethylphenidate—Somnolence—Galantamine—Alzheimer's disease	0.000186	0.000866	CcSEcCtD
Dexmethylphenidate—Chills—Memantine—Alzheimer's disease	0.000186	0.000866	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Memantine—Alzheimer's disease	0.000185	0.000862	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000185	0.000858	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Galantamine—Alzheimer's disease	0.000184	0.000858	CcSEcCtD
Dexmethylphenidate—Angiopathy—Rivastigmine—Alzheimer's disease	0.000184	0.000856	CcSEcCtD
Dexmethylphenidate—Anaemia—Donepezil—Alzheimer's disease	0.000184	0.000855	CcSEcCtD
Dexmethylphenidate—Alopecia—Memantine—Alzheimer's disease	0.000183	0.000853	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000183	0.000851	CcSEcCtD
Dexmethylphenidate—Agitation—Donepezil—Alzheimer's disease	0.000183	0.00085	CcSEcCtD
Dexmethylphenidate—Chills—Rivastigmine—Alzheimer's disease	0.000182	0.000847	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Galantamine—Alzheimer's disease	0.000182	0.000847	CcSEcCtD
Dexmethylphenidate—Mental disorder—Memantine—Alzheimer's disease	0.000182	0.000845	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000181	0.000843	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000181	0.000841	CcSEcCtD
Dexmethylphenidate—Malnutrition—Memantine—Alzheimer's disease	0.000181	0.00084	CcSEcCtD
Dexmethylphenidate—Fatigue—Galantamine—Alzheimer's disease	0.000181	0.00084	CcSEcCtD
Dexmethylphenidate—Malaise—Donepezil—Alzheimer's disease	0.000179	0.000834	CcSEcCtD
Dexmethylphenidate—Alopecia—Rivastigmine—Alzheimer's disease	0.000179	0.000834	CcSEcCtD
Dexmethylphenidate—Constipation—Galantamine—Alzheimer's disease	0.000179	0.000833	CcSEcCtD
Dexmethylphenidate—Vertigo—Donepezil—Alzheimer's disease	0.000179	0.000831	CcSEcCtD
Dexmethylphenidate—Syncope—Donepezil—Alzheimer's disease	0.000178	0.00083	CcSEcCtD
Dexmethylphenidate—Mental disorder—Rivastigmine—Alzheimer's disease	0.000178	0.000827	CcSEcCtD
Dexmethylphenidate—Tension—Memantine—Alzheimer's disease	0.000177	0.000824	CcSEcCtD
Dexmethylphenidate—Malnutrition—Rivastigmine—Alzheimer's disease	0.000177	0.000822	CcSEcCtD
Dexmethylphenidate—Erythema—Rivastigmine—Alzheimer's disease	0.000177	0.000822	CcSEcCtD
Dexmethylphenidate—Nervousness—Memantine—Alzheimer's disease	0.000175	0.000816	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Donepezil—Alzheimer's disease	0.000175	0.000813	CcSEcCtD
Dexmethylphenidate—Back pain—Memantine—Alzheimer's disease	0.000175	0.000813	CcSEcCtD
Dexmethylphenidate—Cough—Donepezil—Alzheimer's disease	0.000174	0.000807	CcSEcCtD
Dexmethylphenidate—Tension—Rivastigmine—Alzheimer's disease	0.000173	0.000806	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Galantamine—Alzheimer's disease	0.000173	0.000803	CcSEcCtD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	0.000172	0.00586	CbGpPWpGaD
Dexmethylphenidate—Convulsion—Donepezil—Alzheimer's disease	0.000172	0.000802	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000172	0.00585	CbGpPWpGaD
Dexmethylphenidate—Hypertension—Donepezil—Alzheimer's disease	0.000172	0.000799	CcSEcCtD
Dexmethylphenidate—Nervousness—Rivastigmine—Alzheimer's disease	0.000172	0.000798	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000171	0.000797	CcSEcCtD
Dexmethylphenidate—Back pain—Rivastigmine—Alzheimer's disease	0.000171	0.000795	CcSEcCtD
Dexmethylphenidate—Vision blurred—Memantine—Alzheimer's disease	0.00017	0.000792	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00017	0.00079	CcSEcCtD
Dexmethylphenidate—Chest pain—Donepezil—Alzheimer's disease	0.000169	0.000788	CcSEcCtD
Dexmethylphenidate—Myalgia—Donepezil—Alzheimer's disease	0.000169	0.000788	CcSEcCtD
Dexmethylphenidate—Arthralgia—Donepezil—Alzheimer's disease	0.000169	0.000788	CcSEcCtD
Dexmethylphenidate—Tremor—Memantine—Alzheimer's disease	0.000169	0.000787	CcSEcCtD
Dexmethylphenidate—Anxiety—Donepezil—Alzheimer's disease	0.000169	0.000785	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Memantine—Alzheimer's disease	0.000168	0.000779	CcSEcCtD
Dexmethylphenidate—Discomfort—Donepezil—Alzheimer's disease	0.000167	0.000778	CcSEcCtD
Dexmethylphenidate—Anaemia—Memantine—Alzheimer's disease	0.000167	0.000776	CcSEcCtD
Dexmethylphenidate—Vision blurred—Rivastigmine—Alzheimer's disease	0.000167	0.000774	CcSEcCtD
Dexmethylphenidate—Agitation—Memantine—Alzheimer's disease	0.000166	0.000772	CcSEcCtD
Dexmethylphenidate—Dry mouth—Donepezil—Alzheimer's disease	0.000166	0.00077	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Galantamine—Alzheimer's disease	0.000166	0.00077	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Galantamine—Alzheimer's disease	0.000166	0.00077	CcSEcCtD
Dexmethylphenidate—Tremor—Rivastigmine—Alzheimer's disease	0.000166	0.00077	CcSEcCtD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	0.000166	0.00562	CbGpPWpGaD
Dexmethylphenidate—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000164	0.000762	CcSEcCtD
Dexmethylphenidate—Confusional state—Donepezil—Alzheimer's disease	0.000164	0.000761	CcSEcCtD
Dexmethylphenidate—Anaemia—Rivastigmine—Alzheimer's disease	0.000163	0.00076	CcSEcCtD
Dexmethylphenidate—SLC6A3—Neuronal System—SLC18A3—Alzheimer's disease	0.000163	0.00554	CbGpPWpGaD
Dexmethylphenidate—Malaise—Memantine—Alzheimer's disease	0.000163	0.000758	CcSEcCtD
Dexmethylphenidate—Agitation—Rivastigmine—Alzheimer's disease	0.000162	0.000755	CcSEcCtD
Dexmethylphenidate—Oedema—Donepezil—Alzheimer's disease	0.000162	0.000755	CcSEcCtD
Dexmethylphenidate—Vertigo—Memantine—Alzheimer's disease	0.000162	0.000755	CcSEcCtD
Dexmethylphenidate—Syncope—Memantine—Alzheimer's disease	0.000162	0.000753	CcSEcCtD
Dexmethylphenidate—Leukopenia—Memantine—Alzheimer's disease	0.000162	0.000752	CcSEcCtD
Dexmethylphenidate—SLC6A2—Monoamine Transport—IL1B—Alzheimer's disease	0.000161	0.00548	CbGpPWpGaD
Dexmethylphenidate—Infection—Donepezil—Alzheimer's disease	0.000161	0.00075	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.00016	0.00544	CbGpPWpGaD
Dexmethylphenidate—Shock—Donepezil—Alzheimer's disease	0.00016	0.000743	CcSEcCtD
Dexmethylphenidate—Palpitations—Memantine—Alzheimer's disease	0.00016	0.000742	CcSEcCtD
Dexmethylphenidate—Malaise—Rivastigmine—Alzheimer's disease	0.000159	0.000741	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Donepezil—Alzheimer's disease	0.000159	0.00074	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000159	0.000739	CcSEcCtD
Dexmethylphenidate—Vertigo—Rivastigmine—Alzheimer's disease	0.000159	0.000738	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Memantine—Alzheimer's disease	0.000159	0.000738	CcSEcCtD
Dexmethylphenidate—Syncope—Rivastigmine—Alzheimer's disease	0.000158	0.000737	CcSEcCtD
Dexmethylphenidate—Cough—Memantine—Alzheimer's disease	0.000158	0.000733	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000157	0.00073	CcSEcCtD
Dexmethylphenidate—Convulsion—Memantine—Alzheimer's disease	0.000157	0.000728	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000156	0.00531	CbGpPWpGaD
Dexmethylphenidate—Palpitations—Rivastigmine—Alzheimer's disease	0.000156	0.000726	CcSEcCtD
Dexmethylphenidate—Hypertension—Memantine—Alzheimer's disease	0.000156	0.000725	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000155	0.000722	CcSEcCtD
Dexmethylphenidate—Anorexia—Donepezil—Alzheimer's disease	0.000155	0.00072	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000155	0.00525	CbGpPWpGaD
Dexmethylphenidate—Hypersensitivity—Galantamine—Alzheimer's disease	0.000154	0.000718	CcSEcCtD
Dexmethylphenidate—Cough—Rivastigmine—Alzheimer's disease	0.000154	0.000717	CcSEcCtD
Dexmethylphenidate—Myalgia—Memantine—Alzheimer's disease	0.000154	0.000715	CcSEcCtD
Dexmethylphenidate—Arthralgia—Memantine—Alzheimer's disease	0.000154	0.000715	CcSEcCtD
Dexmethylphenidate—Chest pain—Memantine—Alzheimer's disease	0.000154	0.000715	CcSEcCtD
Dexmethylphenidate—Anxiety—Memantine—Alzheimer's disease	0.000153	0.000713	CcSEcCtD
Dexmethylphenidate—Convulsion—Rivastigmine—Alzheimer's disease	0.000153	0.000712	CcSEcCtD
Dexmethylphenidate—Hypertension—Rivastigmine—Alzheimer's disease	0.000153	0.000709	CcSEcCtD
Dexmethylphenidate—Discomfort—Memantine—Alzheimer's disease	0.000152	0.000707	CcSEcCtD
Dexmethylphenidate—Myalgia—Rivastigmine—Alzheimer's disease	0.00015	0.0007	CcSEcCtD
Dexmethylphenidate—Arthralgia—Rivastigmine—Alzheimer's disease	0.00015	0.0007	CcSEcCtD
Dexmethylphenidate—Chest pain—Rivastigmine—Alzheimer's disease	0.00015	0.0007	CcSEcCtD
Dexmethylphenidate—Dry mouth—Memantine—Alzheimer's disease	0.00015	0.000699	CcSEcCtD
Dexmethylphenidate—Asthenia—Galantamine—Alzheimer's disease	0.00015	0.000699	CcSEcCtD
Dexmethylphenidate—Anxiety—Rivastigmine—Alzheimer's disease	0.00015	0.000697	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.00015	0.00509	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.00015	0.00509	CbGpPWpGaD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000149	0.000695	CcSEcCtD
Dexmethylphenidate—Confusional state—Memantine—Alzheimer's disease	0.000149	0.000691	CcSEcCtD
Dexmethylphenidate—Discomfort—Rivastigmine—Alzheimer's disease	0.000149	0.000691	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000148	0.000688	CcSEcCtD
Dexmethylphenidate—Oedema—Memantine—Alzheimer's disease	0.000147	0.000686	CcSEcCtD
Dexmethylphenidate—Dry mouth—Rivastigmine—Alzheimer's disease	0.000147	0.000684	CcSEcCtD
Dexmethylphenidate—Insomnia—Donepezil—Alzheimer's disease	0.000147	0.000683	CcSEcCtD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	0.000147	0.00498	CbGpPWpGaD
Dexmethylphenidate—Infection—Memantine—Alzheimer's disease	0.000146	0.000681	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Donepezil—Alzheimer's disease	0.000146	0.000678	CcSEcCtD
Dexmethylphenidate—Confusional state—Rivastigmine—Alzheimer's disease	0.000145	0.000676	CcSEcCtD
Dexmethylphenidate—Shock—Memantine—Alzheimer's disease	0.000145	0.000674	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Donepezil—Alzheimer's disease	0.000145	0.000673	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Memantine—Alzheimer's disease	0.000145	0.000672	CcSEcCtD
Dexmethylphenidate—Somnolence—Donepezil—Alzheimer's disease	0.000144	0.000671	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Memantine—Alzheimer's disease	0.000144	0.000671	CcSEcCtD
Dexmethylphenidate—Oedema—Rivastigmine—Alzheimer's disease	0.000144	0.000671	CcSEcCtD
Dexmethylphenidate—Tachycardia—Memantine—Alzheimer's disease	0.000144	0.000669	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Galantamine—Alzheimer's disease	0.000143	0.000667	CcSEcCtD
Dexmethylphenidate—Infection—Rivastigmine—Alzheimer's disease	0.000143	0.000666	CcSEcCtD
Dexmethylphenidate—Skin disorder—Memantine—Alzheimer's disease	0.000143	0.000666	CcSEcCtD
Dexmethylphenidate—SLC6A3—Monoamine Transport—IL1B—Alzheimer's disease	0.000143	0.00486	CbGpPWpGaD
Dexmethylphenidate—Dyspepsia—Donepezil—Alzheimer's disease	0.000143	0.000665	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000143	0.00485	CbGpPWpGaD
Dexmethylphenidate—Hyperhidrosis—Memantine—Alzheimer's disease	0.000143	0.000663	CcSEcCtD
Dexmethylphenidate—Shock—Rivastigmine—Alzheimer's disease	0.000142	0.00066	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000142	0.00482	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000141	0.00481	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000141	0.00481	CbGpPWpGaD
Dexmethylphenidate—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000141	0.000658	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000141	0.000657	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Donepezil—Alzheimer's disease	0.000141	0.000656	CcSEcCtD
Dexmethylphenidate—Tachycardia—Rivastigmine—Alzheimer's disease	0.000141	0.000655	CcSEcCtD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—CHRNB2—Alzheimer's disease	0.000141	0.00478	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—CST3—Alzheimer's disease	0.000141	0.00478	CbGpPWpGaD
Dexmethylphenidate—Anorexia—Memantine—Alzheimer's disease	0.000141	0.000653	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00014	0.000652	CcSEcCtD
Dexmethylphenidate—Skin disorder—Rivastigmine—Alzheimer's disease	0.00014	0.000651	CcSEcCtD
Dexmethylphenidate—Fatigue—Donepezil—Alzheimer's disease	0.00014	0.000651	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000139	0.000648	CcSEcCtD
Dexmethylphenidate—Constipation—Donepezil—Alzheimer's disease	0.000139	0.000646	CcSEcCtD
Dexmethylphenidate—Pain—Donepezil—Alzheimer's disease	0.000139	0.000646	CcSEcCtD
Dexmethylphenidate—Dizziness—Galantamine—Alzheimer's disease	0.000139	0.000644	CcSEcCtD
Dexmethylphenidate—Anorexia—Rivastigmine—Alzheimer's disease	0.000137	0.000639	CcSEcCtD
Dexmethylphenidate—SLC6A4—Monoamine Transport—TNF—Alzheimer's disease	0.000136	0.00463	CbGpPWpGaD
Dexmethylphenidate—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000134	0.000625	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Donepezil—Alzheimer's disease	0.000134	0.000622	CcSEcCtD
Dexmethylphenidate—Insomnia—Memantine—Alzheimer's disease	0.000133	0.00062	CcSEcCtD
Dexmethylphenidate—Vomiting—Galantamine—Alzheimer's disease	0.000133	0.000619	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000133	0.000617	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Memantine—Alzheimer's disease	0.000132	0.000616	CcSEcCtD
Dexmethylphenidate—Rash—Galantamine—Alzheimer's disease	0.000132	0.000614	CcSEcCtD
Dexmethylphenidate—Dermatitis—Galantamine—Alzheimer's disease	0.000132	0.000614	CcSEcCtD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC6A4—Alzheimer's disease	0.000132	0.00448	CbGpPWpGaD
Dexmethylphenidate—Dyspnoea—Memantine—Alzheimer's disease	0.000131	0.000611	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000131	0.000611	CcSEcCtD
Dexmethylphenidate—Headache—Galantamine—Alzheimer's disease	0.000131	0.00061	CcSEcCtD
Dexmethylphenidate—Somnolence—Memantine—Alzheimer's disease	0.000131	0.000609	CcSEcCtD
Dexmethylphenidate—Insomnia—Rivastigmine—Alzheimer's disease	0.00013	0.000607	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Memantine—Alzheimer's disease	0.00013	0.000603	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00013	0.000602	CcSEcCtD
Dexmethylphenidate—Urticaria—Donepezil—Alzheimer's disease	0.000129	0.0006	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000129	0.000598	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Donepezil—Alzheimer's disease	0.000128	0.000597	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Donepezil—Alzheimer's disease	0.000128	0.000597	CcSEcCtD
Dexmethylphenidate—Somnolence—Rivastigmine—Alzheimer's disease	0.000128	0.000596	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Memantine—Alzheimer's disease	0.000128	0.000596	CcSEcCtD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—CRH—Alzheimer's disease	0.000128	0.00434	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000127	0.00433	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000127	0.00433	CbGpPWpGaD
Dexmethylphenidate—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000127	0.000592	CcSEcCtD
Dexmethylphenidate—Fatigue—Memantine—Alzheimer's disease	0.000127	0.000591	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000127	0.00059	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000126	0.0043	CbGpPWpGaD
Dexmethylphenidate—Constipation—Memantine—Alzheimer's disease	0.000126	0.000586	CcSEcCtD
Dexmethylphenidate—Pain—Memantine—Alzheimer's disease	0.000126	0.000586	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000125	0.000583	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000125	0.000579	CcSEcCtD
Dexmethylphenidate—Nausea—Galantamine—Alzheimer's disease	0.000124	0.000579	CcSEcCtD
Dexmethylphenidate—SLC6A3—Parkinsons Disease Pathway—CASP3—Alzheimer's disease	0.000124	0.00423	CbGpPWpGaD
Dexmethylphenidate—Fatigue—Rivastigmine—Alzheimer's disease	0.000124	0.000578	CcSEcCtD
Dexmethylphenidate—Constipation—Rivastigmine—Alzheimer's disease	0.000123	0.000574	CcSEcCtD
Dexmethylphenidate—Pain—Rivastigmine—Alzheimer's disease	0.000123	0.000574	CcSEcCtD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000122	0.00413	CbGpPWpGaD
Dexmethylphenidate—Feeling abnormal—Memantine—Alzheimer's disease	0.000122	0.000565	CcSEcCtD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—NPS—Alzheimer's disease	0.000121	0.00411	CbGpPWpGaD
Dexmethylphenidate—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000121	0.000561	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Donepezil—Alzheimer's disease	0.00012	0.000556	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000119	0.000553	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000118	0.000548	CcSEcCtD
Dexmethylphenidate—SLC6A2—Monoamine Transport—TNF—Alzheimer's disease	0.000117	0.00398	CbGpPWpGaD
Dexmethylphenidate—Urticaria—Memantine—Alzheimer's disease	0.000117	0.000545	CcSEcCtD
Dexmethylphenidate—SLC6A3—Dopaminergic Neurogenesis—TGFB1—Alzheimer's disease	0.000117	0.00398	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC6A4—Alzheimer's disease	0.000117	0.00397	CbGpPWpGaD
Dexmethylphenidate—Abdominal pain—Memantine—Alzheimer's disease	0.000117	0.000542	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Memantine—Alzheimer's disease	0.000117	0.000542	CcSEcCtD
Dexmethylphenidate—Asthenia—Donepezil—Alzheimer's disease	0.000117	0.000542	CcSEcCtD
Dexmethylphenidate—Pruritus—Donepezil—Alzheimer's disease	0.000115	0.000534	CcSEcCtD
Dexmethylphenidate—SLC6A3—Neuronal System—CHRNA7—Alzheimer's disease	0.000115	0.0039	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GRIK1—Alzheimer's disease	0.000115	0.0039	CbGpPWpGaD
Dexmethylphenidate—Urticaria—Rivastigmine—Alzheimer's disease	0.000115	0.000533	CcSEcCtD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—CALM1—Alzheimer's disease	0.000114	0.00388	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—HMOX1—Alzheimer's disease	0.000114	0.00388	CbGpPWpGaD
Dexmethylphenidate—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000114	0.00053	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000114	0.00053	CcSEcCtD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—APOE—Alzheimer's disease	0.000114	0.00386	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000114	0.00386	CbGpPWpGaD
Dexmethylphenidate—Diarrhoea—Donepezil—Alzheimer's disease	0.000111	0.000517	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000109	0.00369	CbGpPWpGaD
Dexmethylphenidate—Hypersensitivity—Memantine—Alzheimer's disease	0.000109	0.000505	CcSEcCtD
Dexmethylphenidate—CYP2D6—Biological oxidations—CYP46A1—Alzheimer's disease	0.000108	0.00368	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000108	0.00365	CbGpPWpGaD
Dexmethylphenidate—Dizziness—Donepezil—Alzheimer's disease	0.000107	0.000499	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000107	0.00363	CbGpPWpGaD
Dexmethylphenidate—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000106	0.000494	CcSEcCtD
Dexmethylphenidate—Asthenia—Memantine—Alzheimer's disease	0.000106	0.000492	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000106	0.00359	CbGpPWpGaD
Dexmethylphenidate—Pruritus—Memantine—Alzheimer's disease	0.000104	0.000485	CcSEcCtD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.000104	0.00353	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Monoamine Transport—TNF—Alzheimer's disease	0.000104	0.00353	CbGpPWpGaD
Dexmethylphenidate—Asthenia—Rivastigmine—Alzheimer's disease	0.000103	0.000481	CcSEcCtD
Dexmethylphenidate—Vomiting—Donepezil—Alzheimer's disease	0.000103	0.00048	CcSEcCtD
Dexmethylphenidate—SLC6A4—NRF2 pathway—AGER—Alzheimer's disease	0.000103	0.00348	CbGpPWpGaD
Dexmethylphenidate—Rash—Donepezil—Alzheimer's disease	0.000102	0.000476	CcSEcCtD
Dexmethylphenidate—Dermatitis—Donepezil—Alzheimer's disease	0.000102	0.000476	CcSEcCtD
Dexmethylphenidate—Pruritus—Rivastigmine—Alzheimer's disease	0.000102	0.000474	CcSEcCtD
Dexmethylphenidate—Headache—Donepezil—Alzheimer's disease	0.000102	0.000473	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000101	0.00344	CbGpPWpGaD
Dexmethylphenidate—Diarrhoea—Memantine—Alzheimer's disease	0.000101	0.000469	CcSEcCtD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—NGFR—Alzheimer's disease	9.91e-05	0.00337	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	9.89e-05	0.00336	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	9.88e-05	0.00336	CbGpPWpGaD
Dexmethylphenidate—Diarrhoea—Rivastigmine—Alzheimer's disease	9.87e-05	0.000459	CcSEcCtD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	9.85e-05	0.00335	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—HMOX1—Alzheimer's disease	9.81e-05	0.00333	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	9.81e-05	0.00333	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	9.77e-05	0.00332	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—CHAT—Alzheimer's disease	9.77e-05	0.00332	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GRIK2—Alzheimer's disease	9.77e-05	0.00332	CbGpPWpGaD
Dexmethylphenidate—Dizziness—Memantine—Alzheimer's disease	9.75e-05	0.000453	CcSEcCtD
Dexmethylphenidate—Nausea—Donepezil—Alzheimer's disease	9.65e-05	0.000448	CcSEcCtD
Dexmethylphenidate—Dizziness—Rivastigmine—Alzheimer's disease	9.54e-05	0.000443	CcSEcCtD
Dexmethylphenidate—Vomiting—Memantine—Alzheimer's disease	9.37e-05	0.000436	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	9.37e-05	0.00318	CbGpPWpGaD
Dexmethylphenidate—Rash—Memantine—Alzheimer's disease	9.3e-05	0.000432	CcSEcCtD
Dexmethylphenidate—Dermatitis—Memantine—Alzheimer's disease	9.29e-05	0.000432	CcSEcCtD
Dexmethylphenidate—Headache—Memantine—Alzheimer's disease	9.24e-05	0.000429	CcSEcCtD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	9.21e-05	0.00313	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—CP—Alzheimer's disease	9.21e-05	0.00313	CbGpPWpGaD
Dexmethylphenidate—Vomiting—Rivastigmine—Alzheimer's disease	9.17e-05	0.000426	CcSEcCtD
Dexmethylphenidate—Rash—Rivastigmine—Alzheimer's disease	9.09e-05	0.000423	CcSEcCtD
Dexmethylphenidate—Dermatitis—Rivastigmine—Alzheimer's disease	9.09e-05	0.000422	CcSEcCtD
Dexmethylphenidate—Headache—Rivastigmine—Alzheimer's disease	9.04e-05	0.00042	CcSEcCtD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	8.92e-05	0.00303	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—PPARGC1A—Alzheimer's disease	8.87e-05	0.00301	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—AGER—Alzheimer's disease	8.81e-05	0.00299	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	8.77e-05	0.00298	CbGpPWpGaD
Dexmethylphenidate—Nausea—Memantine—Alzheimer's disease	8.76e-05	0.000407	CcSEcCtD
Dexmethylphenidate—SLC6A3—Neuronal System—GRIA1—Alzheimer's disease	8.7e-05	0.00296	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—HMOX1—Alzheimer's disease	8.69e-05	0.00295	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	8.61e-05	0.00292	CbGpPWpGaD
Dexmethylphenidate—Nausea—Rivastigmine—Alzheimer's disease	8.57e-05	0.000398	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—APOD—Alzheimer's disease	8.41e-05	0.00286	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	8.4e-05	0.00285	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—CHRNB2—Alzheimer's disease	8.24e-05	0.0028	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	8.21e-05	0.00279	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	8.12e-05	0.00276	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—PRKCG—Alzheimer's disease	7.86e-05	0.00267	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—AGER—Alzheimer's disease	7.81e-05	0.00265	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—ACHE—Alzheimer's disease	7.57e-05	0.00257	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—CHRNA4—Alzheimer's disease	7.49e-05	0.00254	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—APOD—Alzheimer's disease	7.45e-05	0.00253	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	7.13e-05	0.00242	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—LEP—Alzheimer's disease	6.77e-05	0.0023	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—BCHE—Alzheimer's disease	6.6e-05	0.00224	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—MAOB—Alzheimer's disease	6.46e-05	0.00219	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—DLG4—Alzheimer's disease	6.44e-05	0.00219	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—NOS2—Alzheimer's disease	6.31e-05	0.00214	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GRIN2B—Alzheimer's disease	6.29e-05	0.00214	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—PLCB1—Alzheimer's disease	6.22e-05	0.00211	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	6.01e-05	0.00204	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—PPARG—Alzheimer's disease	5.9e-05	0.002	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—GSK3B—Alzheimer's disease	5.87e-05	0.00199	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—CREB1—Alzheimer's disease	5.82e-05	0.00198	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	5.29e-05	0.0018	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—CP—Alzheimer's disease	5.28e-05	0.00179	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	5.28e-05	0.00179	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	5.2e-05	0.00177	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—PTGS1—Alzheimer's disease	4.89e-05	0.00166	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—CP—Alzheimer's disease	4.68e-05	0.00159	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—PRKCG—Alzheimer's disease	4.6e-05	0.00156	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—TF—Alzheimer's disease	4.49e-05	0.00153	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	4.48e-05	0.00152	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	4.45e-05	0.00151	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—TGFB1—Alzheimer's disease	4.33e-05	0.00147	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—CALM1—Alzheimer's disease	3.98e-05	0.00135	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—TF—Alzheimer's disease	3.98e-05	0.00135	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—MAPK8—Alzheimer's disease	3.96e-05	0.00134	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	3.84e-05	0.0013	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—TGFB1—Alzheimer's disease	3.73e-05	0.00127	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—CREB1—Alzheimer's disease	3.41e-05	0.00116	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—TGFB1—Alzheimer's disease	3.3e-05	0.00112	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	3.14e-05	0.00107	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	3.1e-05	0.00105	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.78e-05	0.000945	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	2.77e-05	0.000942	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—TP53—Alzheimer's disease	2.76e-05	0.000938	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—IL6—Alzheimer's disease	2.53e-05	0.000859	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CA4—Alzheimer's disease	2.36e-05	0.000801	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	2.22e-05	0.000753	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	2.1e-05	0.000714	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PLD3—Alzheimer's disease	2.01e-05	0.000681	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.92e-05	0.000653	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.85e-05	0.000629	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.79e-05	0.000607	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.15e-05	0.000391	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.15e-05	0.000391	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.1e-05	0.000375	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	1.06e-05	0.000361	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—A2M—Alzheimer's disease	1.03e-05	0.000349	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ACHE—Alzheimer's disease	8.93e-06	0.000303	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	8.83e-06	0.0003	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ENO1—Alzheimer's disease	8.37e-06	0.000284	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	8.37e-06	0.000284	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—BCHE—Alzheimer's disease	7.78e-06	0.000264	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	7.34e-06	0.000249	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	7.12e-06	0.000242	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	6.13e-06	0.000208	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	6.11e-06	0.000207	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.59e-06	0.00019	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	5.03e-06	0.000171	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.7e-06	0.00016	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.68e-06	0.000159	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.64e-06	0.000158	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PPARG—Alzheimer's disease	4.08e-06	0.000139	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—INS—Alzheimer's disease	4e-06	0.000136	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.51e-06	0.000119	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	3.21e-06	0.000109	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.61e-06	5.48e-05	CbGpPWpGaD
